SCHEMBL27188316

SCHEMBL27188316

CCc1ccc(-c2nc3cc(NC(=O)O)ccc3o2)cc1

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PPARG P37231 7/20 0.77
▸ MAPT P10636 3/20 0.74
▸ POLB P06746 3/20 0.74
▸ TP53 P04637 4/20 0.72
▸ SMN1; SMN2 Q16637 4/20 0.72
▸ NPC1 O15118 3/20 0.72
▸ RAB9A P51151 3/20 0.72
▸ CASP3 P42574 2/20 0.72
▸ SENP8 Q96LD8 2/20 0.72
▸ SENP7 Q9BQF6 2/20 0.72
▸ SENP6 Q9GZR1 2/20 0.72
▸ RXFP1 Q9HBX9 1/20 0.67
▸ ALDH1A1 P00352 3/20 0.64
▸ KDM4E B2RXH2 2/20 0.64
▸ HPGD P15428 2/20 0.63
▸ HSD17B10 Q99714 2/20 0.63
▸ PTPN2 P17706 1/20 0.62
▸ PTPN1 P18031 1/20 0.62
▸ PTPN5 P54829 1/20 0.62
▸ HPSE Q9Y251 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27188294 0.87 PPARG (1.00) PPARGMAPTPOLBTP53SMN1; SMN2
SCHEMBL30782729 0.85 PPARG (0.67) PPARGMAPTPOLBTP53SMN1; SMN2
SCHEMBL27188301 0.83 PPARG (0.64) PPARGMAPTPOLBTP53SMN1; SMN2
SCHEMBL2244672 0.81 CASP3 (0.80) MAPTPOLBTP53SMN1; SMN2NPC1
SCHEMBL19428453 0.80 MAPT (0.76) PPARGMAPTPOLBTP53SMN1; SMN2
SCHEMBL27188664 0.80 MAPT (0.67) PPARGMAPTPOLBTP53SMN1; SMN2
SCHEMBL2244809 0.80 NPC1 (0.85) MAPTPOLBTP53SMN1; SMN2NPC1
SCHEMBL2240780 0.80 CHIA (0.79) PPARGMAPTPOLBTP53SMN1; SMN2
SCHEMBL2245659 0.80 ALDH1A1 (0.87) MAPTPOLBTP53SMN1; SMN2NPC1
SCHEMBL27188337 0.79 PPARG (0.63) PPARGMAPTPOLBTP53SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240109850-A1 Covalent PPARG inverse-agonists BAYER AKTIENGESELLSCHAFT (DE) 2024-04-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240109850-A1 Covalent PPARG inverse-agonists PPARG, PPARD, PPARA PPARG 1/4885MAPT 4826/4885POLB 456/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback